- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05741216
Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers
October 10, 2023 updated by: Alcon Research
The purpose of this study is to evaluate the ocular comfort of 3 ocular lubricants and a comparator.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The expected duration of subject participation is at least 7 days.
This study will be conducted in Australia and Canada.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alcon Call Center
- Phone Number: 1-888-451-3937
- Email: alcon.medinfo@alcon.com
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2052
- School of Optometry and Vision
-
-
Victoria
-
Waurn Ponds, Victoria, Australia, 3216
- Deakin Collaborative Eye Care Clinic, Deakin University
-
-
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L3G1
- School of Optometry and Vision Science, University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Key Inclusion Criteria:
- Is able to understand and sign an approved information consent letter;
- Habitually wears daily disposable soft contact lenses in both eyes
- Uses rewetting drops on a regular basis;
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria:
- Routinely sleeps in habitual contact lenses;
- Has any known active ocular disease and/or infection;
- Is pregnant or lactating;
- Other protocol specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: OTF Test 1
One application of ocular lubricant to each eye at night for 5 consecutive nights
|
Ocular lubricant in 1 of 3 test formulations
|
Experimental: OTF Test 2
One application of ocular lubricant to each eye at night for 5 consecutive nights
|
Ocular lubricant in 1 of 3 test formulations
|
Experimental: OTF Test 3
One application of ocular lubricant to each eye at night for 5 consecutive nights
|
Ocular lubricant in 1 of 3 test formulations
|
Active Comparator: Ocular lubricant
One drop of ocular lubricant applied to each eye at night for 5 consecutive nights
|
Commercially available ocular lubricant
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ocular comfort
Time Frame: Up to Day 5
|
Comfort will be rated using a visual analog scale (0-100) from 0-100, where 0=poor and 100=excellent.
|
Up to Day 5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Clinical Trial Lead, Dry Eye, Alcon Research, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
October 2, 2023
Study Completion (Actual)
October 2, 2023
Study Registration Dates
First Submitted
February 14, 2023
First Submitted That Met QC Criteria
February 14, 2023
First Posted (Actual)
February 23, 2023
Study Record Updates
Last Update Posted (Actual)
October 11, 2023
Last Update Submitted That Met QC Criteria
October 10, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DEJ475-E006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Singapore National Eye CentreCompleted
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
Singapore National Eye CentreCompleted
-
LantibioRiver Plate Biotechnology, Inc.; Rx Development Resources, LLCCompletedSafety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye SyndromeDry Eye DiseaseUnited States
Clinical Trials on OTF Ocular Lubricant
-
Alcon ResearchCompletedDry Eye DiseaseAustralia
-
Janssen Research & Development, LLCCompleted
-
Universidad Autonoma de Nuevo LeonHospital Universitario Dr. Jose E. GonzalezRecruitingPersistent Epithelial DefectMexico
-
Alcon ResearchCompleted
-
Alcon ResearchOptometric Technology Group LtdCompletedDry EyeUnited States, United Kingdom
-
Insel Gruppe AG, University Hospital BernStiftung OPOS; Fondation BertarelliRecruiting
-
Church & Dwight Company, Inc.CompletedCumulative IrritationUnited States
-
Reckitt Benckiser Healthcare (UK) LimitedproDERM GmbHCompletedVaginal Dryness | DyspareuniaGermany
-
First Affiliated Hospital of Harbin Medical UniversityUnknown